V. Mutel et al., Characterization of [H-3]quisqualate binding to recombinant rat metabotropic glutamate 1a and 5a receptors and to rat and human brain sections, J NEUROCHEM, 75(6), 2000, pp. 2590-2601
We have investigated the binding properties of [H-3]quisqualate to rat meta
botropic glutamate (mGlu) 1a and 5a receptors and to rat and human brain se
ctions. Saturation isotherms gave K-D values of 27 +/- 4 and 81 +/- 22 nM f
or mGlu1a and mGlu5a receptors, respectively. Several compounds inhibited t
he binding to mGlu1a and mGlu5a receptors concentration-dependently. (S)-4-
Carboxyphenylglycine, (S)-4-carboxy-3-hydroxyphenylglycine, and (R,S)-1-ami
noindan-1,5-dicarboxylic acid, which completely inhibited [H-3]quisqualate
binding to the mGlu5a receptor, were inactive in a functional assay using t
his receptor. The distribution and abundance of binding sites in rat and hu
man brain sections were studied by quantitative receptor radioautography an
d image analysis. Using 10 nM [H-3]quisqualate, a high density of binding w
as detected in various brain regions with the following rank order of incre
asing levels: medulla, thalamus, olfactory bulb, cerebral cortex, spinal co
rd dorsal horn, olfactory tubercle, dentate gyrus molecular layer, CA1-3 or
iens layer of hippocampus, striatum, and cerebellar molecular layer. The io
notropic component of this binding could be inhibited by 30 muM kainate, re
vealing the distribution of mGlu1+5 receptors. The latter were almost compl
etely inhibited by the group I agonist (S)-3,5-dihydroxyphenylglycine. The
binding profile correlated well with the cellular sites of synthesis and re
gional expression of the respective group I receptor proteins revealed by i
n situ hybridization histochemistry and immunohistochemistry, respectively.